Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leflazepidamine for Mild to Moderate Alzheimer's Disease
CTR20131933Phase 2Active
- Sponsor
- Qingdao Huanghai Pharmaceutical
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of leflazepidamine in Alzheimer's disease (AD), sponsored by Qingdao Huanghai Pharmaceutical. Started Oct 2016; status: active.
02
Drugs
leflazepidamine
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on CTR20131933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131933.